NICE recommends new treatment for people with common heart condition

In final draft guidance, NICE has recommended Apixaban (Eliquis, Bristol-Myers Squibb and Pfizer), in accordance with its licensed indications, for the prevention of stroke and systemic embolism in some people with non-valvular atrial fibrillation.

In Clinical | Tagged ,

Leave a Reply

Leave a comment